- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0022546

About Rakshit Drugs Private Limited
Data last updated:
Rakshit Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 March 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2000PTC034018. Its GSTIN is 36AABCR5942G1ZC (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.24 Cr. It is led by directors including Anjaneya Pattabhi Rameswara Rao Chandana (Managing Director) and Rajeshkumar Joshi (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹256.13 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹5.47 Cr (net margin 2.1%) and EBITDA of ₹18.34 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
The company has about 34 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Rakshit Drugs. As per MCA filings, the company has open charges of ₹60.73 Cr and satisfied charges of ₹20.29 Cr on record. Court records list 15 cases involving the company, including 11 filed by the company and 4 filed against it; 1 case is pending.
Rakshit Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022546). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rakshitdrugspvtltd.com.
Company details
CIN history
Rakshit Drugs has one previous CIN (Corporate Identification Number): U24230AP2000PTC034018. The current CIN is U24230TG2000PTC034018, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2000PTC034018 | Current |
| U24230AP2000PTC034018 | Previous |
Recognitions & Rankings of Rakshit Drugs
Contact details
Rakshit Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is rakshitdrugspvtltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressP.No 28 4th And 5th Floors, HUDA Techno Enclave Sector – III, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Rakshit Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rakshit Drugs operates one associated brand: Rakshit Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients and intermediates are manufactured globally. | rakshitdrugspvtltd.com |
Business activity
The main business activity of Rakshit Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rakshit Drugs Private Limited, buy the company report.
Financials of Rakshit Drugs Private Limited
FY 2025 filings availableRakshit Drugs Private Limited reported revenue of ₹256.13 Cr (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.47 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rakshit Drugs Private Limited, buy the company report.
Board of directors of Rakshit Drugs Private Limited
Rakshit Drugs has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palem Srinivas | Director | 07 Jul 2008 | 18 Years 3 Months | Current |
| Anjaneya Pattabhi Rameswara Rao Chandana Also directs: Organor Chemicals LLP, Srisaichandana Api Private Limited, Azico Biophore India Private Limited and 5 more | Managing Director | 24 Mar 2000 | 26 Years 7 Months | Current |
| Aruna Kumari Chandana Also directs: Azico Biophore India Private Limited, Rakshit Pharmaceuticals Limited, Rakshit Research Centre Private Limited and 1 more | Whole-Time Director | 24 Mar 2000 | 26 Years 7 Months | Current |
| Avinash Shoury Chandana Also directs: Azico Biophore India Private Limited, Azico Pharmaceuticals Private Limited, Rakshit Research Centre Private Limited and 1 more | Director | 25 Feb 2007 | 19 Years 8 Months | Current |
| Bhavani Sankar Alla | Whole-Time Director | 26 Nov 2024 | 1 Years 11 Months | Current |
| Rajeshkumar Joshi Also directs: Azico Biophore India Private Limited | Managing Director | 07 May 2009 | 17 Years 5 Months | Current |
Peer comparison
Rakshit Drugs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sodium Metal Pvt Ltd | ₹273.32 Cr (FY 2023) | -11.0% | Vadodara, Gujarat, India | |||
| Saraf Chemicals Private Limited | ₹271.96 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Venkata Narayana Active Ingredients Private Limited | ₹271.82 Cr (FY 2025) | 53.0% | Chennai, Tamil Nadu, India | |||
| Styrax Pharma Private Limited | ₹260.24 Cr (FY 2024) | 4.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Rakshit Drugs Private Limitedthis company | ₹256.13 Cr (FY 2024) | ₹5.47 Cr | 2.1% | -3.0% | 34 | Hyderabad, Telangana, India |
| Shodhana Laboratories Private Limited | ₹250.16 Cr (FY 2024) | -23.0% | Hyderabad, Telangana, India | |||
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | Kolkata, West Bengal, India | ||||
| Rakshit Pharmaceuticals Limited | ₹238.14 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India | |||
| Century Pharmaceuticals Limited | ₹234.99 Cr (FY 2025) | -1.0% | Vadodara, Gujarat, India | |||
| Delta Finochem Private Limited | ₹234.28 Cr (FY 2025) | -18.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Rakshit Drugs Private Limited, buy the company report.
Auditor
Rakshit Drugs Private Limited is audited by Ramanathan & Rao for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ramanathan & Rao | FY 2023 | 2934S |
Shareholding
The shareholding of Rakshit Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rakshit Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2008 | 10089028 | Others | ₹60.73 Cr | Open | |
| 28 Mar 2017 | 100086867 | Sidbi | ₹90 Lakh | Satisfied | |
| 12 Jun 2009 | 10168794 | Amneal Pharmaceuticals Company (India) Private Limited | ₹13 Cr | Satisfied | |
| 24 Jul 2008 | 10115305 | Hdfc Bank Limited | ₹8.75 Lakh | Satisfied | |
| 26 Apr 2002 | 80001893 | Lakshmi Vilas Bank Limited | ₹6.04 Cr | Satisfied |
To see the full charge records of Rakshit Drugs Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Rakshit Drugs Private Limited has 15 court cases on record: 11 filed by Rakshit Drugs, 4 filed against it. 1 case is pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 1 | 0 |
| District courts | 6 | 3 | 1 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Stein Pharma Pvt Ltd | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Jupiter Bio Science Ltd. | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (MVOP) | Filed against the company | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The Assistant Commissioner of Income Tax Circle 3( and 2 others | Disposed |
To see the full case history of Rakshit Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Rakshit Drugs Private Limited was last rated by Crisil on 27 May 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 27 May 2020 |
To see the full credit ratings and regulatory alerts of Rakshit Drugs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rakshit Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Rakshit Drugs has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Rakshit Research Centre Private Limited | U24303TG2022PTC159416 |
To see the full group structure of Rakshit Drugs Private Limited, buy the company report.
Employees & EPFO
Rakshit Drugs Private Limited has a workforce of 34 employees on its EPFO records as of Oct 28, 2024, across 2 active EPFO establishments.
GST
Rakshit Drugs has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCR5942G1ZC | Telangana | Active | 01 Jul 2017 |
| 37AABCR5942G2Z9 | Andhra Pradesh | Active | 24 Jul 2018 |
To see the full GST registrations and return filing status of Rakshit Drugs Private Limited, buy the company report.
Recent activity
Rakshit Drugs Private Limited has 9 board changes on record since 2000: 6 appointments and 3 cessations. The latest: Bhavani Sankar Alla ceased to be Additional Director on 31 Mar 2025.
16 earlier events are in the company report.
Frequently asked questions
Rakshit Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 March 2000 (26+ years old) and is registered under CIN U24230TG2000PTC034018.
Rakshit Drugs has 6 current directors:
- Anjaneya Pattabhi Rameswara Rao Chandana - Managing Director
- Rajeshkumar Joshi - Managing Director
- Aruna Kumari Chandana - Whole-Time Director
- Bhavani Sankar Alla - Whole-Time Director
- Palem Srinivas - Director
- Avinash Shoury Chandana - Director
The latest financial statements of Rakshit Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rakshit Drugs is 36AABCR5942G1ZC, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AABCR5942G2Z9 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Rakshit Drugs is U24230TG2000PTC034018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rakshit Drugs has 15 court cases on record: 11 filed by the company and 4 filed against it. 1 is pending. Most are in the high courts.
Rakshit Drugs was incorporated on 24 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rakshit Drugs by revenue are Sodium Metal Pvt Ltd, Saraf Chemicals Private Limited, Venkata Narayana Active Ingredients Private Limited, Styrax Pharma Private Limited, Shodhana Laboratories Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhavani Sankar Alla ceased to be Additional Director on 31 Mar 2025. Bhavani Sankar Alla was appointed as Whole-Time Director on 26 Nov 2024. Aruna Kumari Chandana ceased to be Director on 22 Nov 2014. Rakshit Drugs has 9 board changes on record in total.
Yes, Rakshit Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0022546).
Rakshit Drugs can be reached through the website rakshitdrugspvtltd.com. Its registered office is in Hyderabad, Telangana, India.

